Kevin Dennis Hill

Clinical research including outcomes, drug and device trials, short and long term safety and efficacy of interventions and hemodynamic effects of interventions.

Current Appointments & Affiliations

Professor of Pediatrics · 2021 - Present Pediatrics, Cardiology, Pediatrics

Chief, Division of Pediatric Cardiology · 2022 - Present Pediatrics, Cardiology, Pediatrics

Member in the Duke Clinical Research Institute · 2012 - Present Duke Clinical Research Institute, Institutes and Centers

Associate of the Duke Initiative for Science & Society · 2017 - Present Duke Science & Society, University Initiatives & Academic Support Units

In the News

Published November 7, 2022

Largest Randomized Trial Evaluates Steroids for Infant Heart Surgery

Published July 17, 2014

Three Junior Faculty Receive 3-year Funding to Pursue Careers in Translational Medicine

Published June 10, 2014

Lifetime Cancer Risk from Heart Imaging Low for Most Children, but Rises with More Complex Tests

View All News

Recent Publications

Methylprednisolone for Infant Heart Surgery: Subpopulation Analyses of a Randomized Controlled Trial.

Journal Article Crit Care Med · May 21, 2025 OBJECTIVES: Evaluate benefits and harms of prophylactic intraoperative methylprednisolone in subpopulations undergoing infant heart surgery. DESIGN: Subpopulation analyses of The Steroids to Reduce Systemic Inflammation after Infant Heart Surgery (STRESS) ... Full text Link to item Cite

Reexploring the STRESS Trial: Subgroup Postoperative Outcomes Following Methylprednisolone for Infant Heart Surgery.

Journal Article Pediatr Cardiol · May 2, 2025 UNLABELLED: Objective Assess the association between intraoperative methylprednisolone and specific postoperative outcomes among subgroups undergoing infant heart surgery. DESIGN: Subpopulation analyses of The Steroids to Reduce Systemic Inflammation after ... Full text Link to item Cite

Methylated Arginine Metabolites as Biomarkers for Clinical Status and Response to Type 5 Phosphodiesterase Inhibition in Patients With Fontan Circulation.

Journal Article J Am Heart Assoc · April 2025 BACKGROUND: There is significant interest in NO pathway modulators, specifically type 5 phosphodiesterase inhibitors (PDE5is), to treat patients with a Fontan circulation. Trials, however, have had mixed results. The relationship between the NO pathway and ... Full text Link to item Cite

View All Publications

Recent Grants

CORD-CHD: Clamp OR Delay among neonates with Congenital Heart Disease

ResearchPrincipal Investigator · Awarded by Research Institute at Nationwide Children's Hospital · 2024 - 2030

A PHASE 2/3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED AND OPEN-LABEL EXTENSION TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF AFICAMTEN IN A PEDIATRIC POPULATION WITH SYMPTOMATIC OBSTRUC

Clinical TrialPrincipal Investigator · Awarded by Cytokinetics, Inc. · 2025 - 2028

Stimulating Access to Research in Residency (StARR) - NHLBI

Inst. Training Prgm or CMEPreceptor · Awarded by National Heart, Lung, and Blood Institute · 2018 - 2028

View All Grants

Education, Training & Certifications

Wake Forest University · 2002 M.D.